GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK─Oxford Cancer Immuno─
Oxford University is an England-based educational institution that offers undergraduate and postgraduate programs in disciplines such as arts and psychology for students.